Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
H.S. freshman Avg
|
|
New words:
accrual, acquisition, agreed, alternative, andZOSYN, ariad, atrophy, behavior, bipolar, booster, broader, Canadian, Carolina, choice, choose, clarity, client, collaboration, component, confirmation, conjugate, constipation, contrast, demonstrated, Department, dossier, EFFEXORLitigation, elevated, EMEA, endpoint, EU, Europe, examine, examining, expandTYGACIL, extension, forEFFEXORandEFFEXOR, forENBREL, formal, forPREMPROandPREMARINwere, forPREVENAR, forPRISTIQfor, forTORISELfor, forVIVIANTfor, higherENBREL, hot, HT, ideation, inBrowning, inclusion, inclusive, INDERAL, inhibition, inTYGACIL, inZOSYN, IRS, JD, Juan, LA, LLC, marginEFFEXOR, Maryland, menstrual, merit, met, mitigation, neuroscience, night, NIP, nominal, occurrence, ofEFFEXORXR, ofLYBRELwould, ofPREMARINandPREMPRO, ofPREMPROorPREMARIN, ofPRISTIQ, ofProvision, ofTYGACIL, Onondaga, Organization, Osmotica, ourEFFEXORXR, ourLYBREL, outsourced, palliative, party, pathway, paving, permission, placebo, pneumonia, pooled, postmenopausal, premium, priority, productINDERAL, proprietary, PROTONIXand, Psychopharmacologic, published, ranked, regardingEFFEXOR, region, relapse, relationship, restructuring, revenueby, routine, San, sector, seePatent, semiannually, slightly, stake, standalone, step, stockpile, supplier, surveillance, suspension, temporary, testing, thatENBREL, thePREVENAR, tissue, titration, toTYGACIL, tumor, unanimously, undue, unnamed, vaginal, variety, Web, wherePRISTIQ, withInterest, woman, worldwidenet, writing, younger, ZOSYNexpired
Removed:
absence, account, accountability, achievement, acquired, actively, activity, adjusted, aggressively, allege, amortization, amortized, amortizing, amounted, andADVIL, anniversary, annualized, APB, applied, assume, assumption, avoided, bacterial, blended, Brazil, carrying, Castle, certainty, charged, Circuit, claim, classified, combine, comparison, comprehensive, considerable, constitute, core, counsel, criteria, curve, dependent, derived, designed, desvenlafaxine, determining, developed, dismissed, disposal, divested, dividend, divisional, documentation, downstream, effectively, emergence, enrollment, equal, excellence, exercised, expensed, expensing, experience, experiencing, expertise, faced, financing, flow, forfeiture, forma, forPREVNAR, forTYGACILand, frame, fromADVIL, fromSOLGAR, funded, goodwill, Grange, grant, granting, guidance, guiding, half, handled, heavy, history, hold, implemented, improve, inAccrued, incorporate, inCost, inResearch, inSelling, Intangible, interim, Intermediate, intrinsic, investment, Ireland, Kingdom, launchedENBREL, license, life, line, marginSOLGAR, maximum, meaningful, meet, minimize, model, moderating, modified, month, motion, network, norepinephrine, occurred, ofEPOCLER, ofPREMARIN, ofSOLGAR, ofZOTON, operational, opt, opted, optimal, order, ourEFFEXOR, participating, plaintiff, post, Postemployment, PPH, preparing, prescribed, principally, principallyEFFEXOR, principle, pro, proceeding, processing, production, prospective, proven, pseudoephedrine, public, purported, pursue, ranging, ratably, realized, reclassified, recognition, recognize, reduce, relying, remained, renewed, rental, representing, requested, requisite, resistance, resolve, resolving, returned, revised, sale, securing, selected, serotonin, settle, settling, short, side, SNRI, stronger, subjective, subsequent, terminated, termination, thesolgar, theZOSYN, timely, toADVIL, toMINOCIN, toMINOCINin, topic, toSYNVISC, traded, traditional, Trubion, turnover, type, underlying, understanding, unit, unvested, validation, vest, vested, vesting, Virginia, volatility, voluntary, website, wholesale, withENBREL, withinCost, withinResearch, withinSelling, work
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.1 Wyeth 2005 Amended and Restated Stock Incentive Plan
- 12 Computation of Ratio of Earnings to Fixed Charges
- 31.1 Certification of Disclosure As Adopted Pursuant to Section 302
- 31.2 Certification of Disclosure As Adopted Pursuant to Section 302
- 32.1 Certification Pursuant to 18 U.s.c. Section 1350
- 32.2 Certification Pursuant to 18 U.s.c. Section 1350
Related press release
WYE similar filings
Filing view
External links